By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • Orphan Drug Status Granted to BHV-0223 for Spinocerebellar Ataxia – Monthly Prescribing Reference (registration)

Orphan Drug Status Granted to BHV-0223 for Spinocerebellar Ataxia – Monthly Prescribing Reference (registration)

Saturday, 12 March, 2016

Orphan Drug Status Granted to BHV-0223 for Spinocerebellar Ataxia – Monthly Prescribing Reference (registration)

Portage Biotech and Biohaven Pharmaceutical announced that the Food and Drug Administration (FDA) has granted Orphan Drug designation to BHV-0223 for the treatment of spinocerebellar ataxia (SCA). SCA is a progressive, hereditary, ...

Read More

Source:Orphan Drug Status Granted to BHV-0223 for Spinocerebellar Ataxia - Monthly Prescribing Reference (registration)

Categories :
  • Ataxia
  • Latest Headlines
  • Uncategorized
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved